Senior insider sale
SVP and General Counsel at ARCUTIS BIOTHERAPEUTICS, INC. — senior position signals high conviction
$224.5K
9.49K shares
What this filing means
MATSUDA MASARU plans to sell 9.49K shares of ARCUTIS BIOTHERAPEUTICS, INC. valued at approximately $224.5K. Form 144 is a notice of intent to sell restricted or control securities — not a mandatory transaction. This filing provides advance warning of potential selling pressure.
Filed: 8/3/2026ACC: 0001628280-26-051956
Officer· SVP and General Counsel
Since Jan 2022
9.49K
Shares to sell
$224.5K
Approx. market value
1.23K
Acquired (3 months)
1
Planned
1 completed
Securities Acquired — Last 3 Months1
Restricted Stock Vesting
NA
8/1/2026
1.23KTotal acquired1.23K
| Acquisition Date | Type | Amount Acquired | Gift |
|---|---|---|---|
8/1/2026 | Restricted Stock Vesting NA | 1.23K | — |
| Total | 1.23K | ||
Planned & Completed Dispositions2
Completed
—Completed
Units to sell
8.26K
Market value
$192.4K
5/4/2026
Planned — Approximate Date
NASDAQPlanned
Units to sell
1.23K
Market value
$32.1K
8/3/2026
Total
Units
9.49K
Value
$224.5K
| Date | Units to Sell | Approx. Market Value | Exchange | Status |
|---|---|---|---|---|
| Completed | ||||
5/4/2026 | 8.26K | $192.4K | — | Completed |
| Planned — Approximate Date | ||||
8/3/2026 | 1.23K | $32.1K | NASDAQ | Planned |
| Total | 9.49K | $224.5K | ||